SCHEMBL2120209

SCHEMBL2120209

CCCC(Nc1ccc(N(CCC(C)(C)N)C(C)=O)cc1)=C1C(=O)Nc2cc(C(=O)OC)ccc21

nearest known ligand 0.35

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CASP1 P29466 1/20 0.35
KMT2A Q03164 1/20 0.34
CTDSP1 Q9GZU7 1/20 0.34
RXFP1 Q9HBX9 1/20 0.33
POLB P06746 2/20 0.32
TDP1 Q9NUW8 2/20 0.32
TP53 P04637 2/20 0.32
THRB P10828 1/20 0.32
BLM P54132 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
ALDH1A1 P00352 3/20 0.32
KDM4E B2RXH2 1/20 0.32
HPGD P15428 1/20 0.32
LMNA P02545 2/20 0.31
CNR2 P34972 1/20 0.31
BACE1 P56817 2/20 0.30
AURKB Q96GD4 1/20 0.30
MAPT P10636 3/20 0.30
CSF1R P07333 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2124322 0.94 RXFP1 (0.40) KMT2ARXFP1POLBTP53ALDH1A1
SCHEMBL2122025 0.94 KMT2A (0.35) CASP1KMT2ACTDSP1RXFP1POLB
SCHEMBL2119189 0.89 KMT2A (0.36) CASP1KMT2ACTDSP1RXFP1POLB
SCHEMBL2121822 0.87 RXFP1 (0.41) KMT2ARXFP1POLBTP53ALDH1A1
SCHEMBL2120208 0.87 CASP1 (0.38) CASP1KMT2ACTDSP1RXFP1THRB
SCHEMBL2571186 0.87 CASP1 (0.38) CASP1KMT2ACTDSP1RXFP1THRB
SCHEMBL2119767 0.84 RXFP1 (0.42) KMT2ARXFP1POLBTP53ALDH1A1
SCHEMBL2118793 0.84 KMT2A (0.42) CASP1KMT2ACTDSP1RXFP1POLB
SCHEMBL2123671 0.82 POLB (0.40) CASP1KMT2ACTDSP1RXFP1POLB
SCHEMBL479343 0.81 RXFP1 (0.39) KMT2ARXFP1POLBTP53BLM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9844572-B2 Promotion of neuronal integration in neural stem cell grafts LIFE & BRAIN GMBH (DE) 2017-12-19 US disclosed
EP-2411034-B1 PROMOTION OF NEURONAL INTEGRATION IN NEURAL STEM CELL GRAFTS LIFE & BRAIN GMBH (DE) 2017-07-26 EP disclosed
US-20120093832-A1 PROMOTION OF NEURONAL INTEGRATION IN NEURAL STEM CELL GRAFTS LIFE & BRAIN GMBH (DE) 2012-04-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120093832-A1 PROMOTION OF NEURONAL INTEGRATION IN NEURAL STEM CELL GRAFTS DCX, NGF, BDNF CASP1 4185/4885KMT2A 3904/4885CTDSP1 4624/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.